Back to Search
JOHN PLASTARAS, MD
MD
Radiation Oncology Physician
NPI: 1720144512IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
MD424998(PA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonist.
PMID 19276666·Cancer Biol Ther·2009
7-preclinical
Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosis.
PMID 19106634·Cancer Biol Ther·2008
7-preclinical
Commentary: let the tail wag the dog: the case for radioimmunotherapy of low-grade follicular lymphoma.
PMID 18586920·Oncologist·2008
8-other
Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans.
PMID 18285707·Cancer Biol Ther·2008
8-other
Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation.
PMID 17909054·Cancer Res·2007
7-preclinical
Combination therapy with gemcitabine and 5-Fluorouracil: unblocking the pathways to survivin?
PMID 17172810·Cancer Biol Ther·2006
8-other
Paget's disease of the nipple as local recurrence after breast-conservation treatment for early-stage breast cancer.
PMID 16277886·Clin Breast Cancer·2005
5-case
Effects of DNA structure on oxopropenylation by the endogenous mutagens malondialdehyde and base propenal.
PMID 11939800·Biochemistry·2002
8-other
Reactivity and mutagenicity of endogenous DNA oxopropenylating agents: base propenals, malondialdehyde, and N(epsilon)-oxopropenyllysine.
PMID 11123964·Chem Res Toxicol·2000
4-observational
Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde.
PMID 10766802·J Biol Chem·2000
7-preclinical
Daily isocenter correction with electromagnetic-based localization improves target coverage and rectal sparing during prostate radiotherapy.
PMID 19625136·Int J Radiat Oncol Biol Phys·2010
8-other
Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients.
PMID 19159077·J Gastroenterol·2009
8-other
Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers.
PMID 19294536·J Gastrointest Cancer·2008
8-other
The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer.
PMID 17980504·Int J Radiat Oncol Biol Phys·2008
8-other
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
PMID 17613437·Cancer Cell·2007
7-preclinical
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
PMID 15721981·Free Radic Biol Med·2005
7-preclinical
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment.
PMID 16294025·Cancer Biol Ther·2005
4-observational
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
PMID 15721980·Free Radic Biol Med·2005
7-preclinical
Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA.
PMID 11896677·Chem Res Toxicol·2002
8-other
Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells.
PMID 11532880·Carcinogenesis·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BLVD, CONCOURSE LEVEL
PHILADELPHIA, PA 19104 - Phone
- (215) 662-2428
Quick Facts
- NPI
- 1720144512
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile